{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:54:06Z","timestamp":1790985246388,"version":"4.1.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272693"],"award-info":[{"award-number":["82272693"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Qilu Health Leading Talents Training Project"},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2022MH048"],"award-info":[{"award-number":["ZR2022MH048"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02146-7","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T13:17:03Z","timestamp":1741958223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Combination therapy with Chicoric acid and PD-1\/PD-L1 blockade improves the immunotherapy response in patient-derived ovarian cancer xenograft model"],"prefix":"10.1186","volume":"23","author":[{"given":"Hongwei","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuantao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingfa","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"key":"2146_CR1","doi-asserted-by":"publisher","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","volume":"2","author":"UA Matulonis","year":"2016","unstructured":"Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Primers. 2016;2:16061.","journal-title":"Nat Rev Dis Primers"},{"key":"2146_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2146_CR3","doi-asserted-by":"crossref","unstructured":"Ghisoni E, Imbimbo M, Zimmermann S, Valabrega G. Ovarian cancer immunotherapy: turning up the heat. Int J Mol Sci 2019, 20.","DOI":"10.3390\/ijms20122927"},{"key":"2146_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.semcancer.2020.12.024","volume":"77","author":"A Ghoneum","year":"2021","unstructured":"Ghoneum A, Almousa S, Warren B, Abdulfattah AY, Shu J, Abouelfadl H, Gonzalez D, Livingston C, Said N. Exploring the clinical value of tumor microenvironment in platinum-resistant ovarian cancer. Semin Cancer Biol. 2021;77:83\u201398.","journal-title":"Semin Cancer Biol"},{"key":"2146_CR5","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1158\/1078-0432.CCR-22-0296","volume":"28","author":"J Xu","year":"2022","unstructured":"Xu J, Fang Y, Chen K, Li S, Tang S, Ren Y, Cen Y, Fei W, Zhang B, Shen Y, Lu W. Single-Cell RNA sequencing reveals the tissue architecture in human High-Grade serous ovarian cancer. Clin Cancer Res. 2022;28:3590\u2013602.","journal-title":"Clin Cancer Res"},{"key":"2146_CR6","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1200\/JCO.19.00508","volume":"37","author":"LE Kandalaft","year":"2019","unstructured":"Kandalaft LE, Odunsi K, Coukos G. Immunotherapy in ovarian cancer: are we there yet?? J Clin Oncol. 2019;37:2460\u201371.","journal-title":"J Clin Oncol"},{"key":"2146_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, B\u00f8rresen-Dale AL, et al. Signatures of mutational processes in human cancer. Nature. 2013;500:415\u201321.","journal-title":"Nature"},{"key":"2146_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1051\/vcm\/2022005","volume":"3","author":"N Zhou","year":"2022","unstructured":"Zhou N, Jiang M, Zhang X. Benefits of precision medicine in lung cancer: experience from a single institution. Vis Cancer Med. 2022;3:4.","journal-title":"Vis Cancer Med"},{"key":"2146_CR9","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1158\/2159-8290.CD-20-0818","volume":"11","author":"S Iyer","year":"2021","unstructured":"Iyer S, Zhang S, Yucel S, Horn H, Smith SG, Reinhardt F, Hoefsmit E, Assatova B, Casado J, Meinsohn MC, et al. Genetically defined syngeneic mouse models of ovarian cancer as tools for the discovery of combination immunotherapy. Cancer Discov. 2021;11:384\u2013407.","journal-title":"Cancer Discov"},{"key":"2146_CR10","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.trecan.2020.02.022","volume":"6","author":"Q Duan","year":"2020","unstructured":"Duan Q, Zhang H, Zheng J, Zhang L. Turning cold into hot: firing up the tumor microenvironment. Trends Cancer. 2020;6:605\u201318.","journal-title":"Trends Cancer"},{"key":"2146_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.copbio.2020.01.003","volume":"63","author":"F Invrea","year":"2020","unstructured":"Invrea F, Rovito R, Torchiaro E, Petti C, Isella C, Medico E. Patient-derived xenografts (PDXs) as model systems for human cancer. Curr Opin Biotechnol. 2020;63:151\u20136.","journal-title":"Curr Opin Biotechnol"},{"key":"2146_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13045-019-0829-z","volume":"13","author":"GJ Yoshida","year":"2020","unstructured":"Yoshida GJ. Applications of patient-derived tumor xenograft models and tumor organoids. J Hematol Oncol. 2020;13:4.","journal-title":"J Hematol Oncol"},{"key":"2146_CR13","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/s41467-021-21300-6","volume":"12","author":"S Karkampouna","year":"2021","unstructured":"Karkampouna S, La Manna F, Benjak A, Kiener M, De Menna M, Zoni E, Grosjean J, Klima I, Garofoli A, Bolis M, et al. Patient-derived xenografts and organoids model therapy response in prostate cancer. Nat Commun. 2021;12:1117.","journal-title":"Nat Commun"},{"key":"2146_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13073-020-00741-6","volume":"12","author":"HW Lee","year":"2020","unstructured":"Lee HW, Chung W, Lee HO, Jeong DE, Jo A, Lim JE, Hong JH, Nam DH, Jeong BC, Park SH, et al. Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient. Genome Med. 2020;12:47.","journal-title":"Genome Med"},{"key":"2146_CR15","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1038\/s41467-021-25177-3","volume":"12","author":"H Sun","year":"2021","unstructured":"Sun H, Cao S, Mashl RJ, Mo CK, Zaccaria S, Wendl MC, Davies SR, Bailey MH, Primeau TM, Hoog J, et al. Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment. Nat Commun. 2021;12:5086.","journal-title":"Nat Commun"},{"key":"2146_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41422-019-0259-z","volume":"30","author":"S Teng","year":"2020","unstructured":"Teng S, Li YE, Yang M, Qi R, Huang Y, Wang Q, Zhang Y, Chen S, Li S, Lin K, et al. Tissue-specific transcription reprogramming promotes liver metastasis of colorectal cancer. Cell Res. 2020;30:34\u201349.","journal-title":"Cell Res"},{"key":"2146_CR17","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1158\/1078-0432.CCR-16-1237","volume":"23","author":"JF Liu","year":"2017","unstructured":"Liu JF, Palakurthi S, Zeng Q, Zhou S, Ivanova E, Huang W, Zervantonakis IK, Selfors LM, Shen Y, Pritchard CC, et al. Establishment of Patient-Derived tumor xenograft models of epithelial ovarian cancer for preclinical evaluation of novel therapeutics. Clin Cancer Res. 2017;23:1263\u201373.","journal-title":"Clin Cancer Res"},{"key":"2146_CR18","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1158\/1078-0432.CCR-16-2273","volume":"23","author":"H Kim","year":"2017","unstructured":"Kim H, George E, Ragland R, Rafail S, Zhang R, Krepler C, Morgan M, Herlyn M, Brown E, Simpkins F. Targeting the ATR\/CHK1 axis with PARP Inhibition results in tumor regression in BRCA-Mutant ovarian cancer models. Clin Cancer Res. 2017;23:3097\u2013108.","journal-title":"Clin Cancer Res"},{"key":"2146_CR19","doi-asserted-by":"publisher","first-page":"e89760","DOI":"10.1172\/jci.insight.89760","volume":"2","author":"E George","year":"2017","unstructured":"George E, Kim H, Krepler C, Wenz B, Makvandi M, Tanyi JL, Brown E, Zhang R, Brafford P, Jean S, et al. A patient-derived-xenograft platform to study BRCA-deficient ovarian cancers. JCI Insight. 2017;2:e89760.","journal-title":"JCI Insight"},{"key":"2146_CR20","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1038\/s41467-018-05564-z","volume":"9","author":"O Kondrashova","year":"2018","unstructured":"Kondrashova O, Topp M, Nesic K, Lieschke E, Ho GY, Harrell MI, Zapparoli GV, Hadley A, Holian R, Boehm E, et al. Methylation of all BRCA1 copies predicts response to the PARP inhibitor Rucaparib in ovarian carcinoma. Nat Commun. 2018;9:3970.","journal-title":"Nat Commun"},{"key":"2146_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13045-016-0318-6","volume":"9","author":"R Dong","year":"2016","unstructured":"Dong R, Qiang W, Guo H, Xu X, Kim JJ, Mazar A, Kong B, Wei JJ. Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma. J Hematol Oncol. 2016;9:92.","journal-title":"J Hematol Oncol"},{"key":"2146_CR22","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/s41591-020-0926-0","volume":"26","author":"B Izar","year":"2020","unstructured":"Izar B, Tirosh I, Stover EH, Wakiro I, Cuoco MS, Alter I, Rodman C, Leeson R, Su MJ, Shah P, et al. A single-cell landscape of high-grade serous ovarian cancer. Nat Med. 2020;26:1271\u20139.","journal-title":"Nat Med"},{"key":"2146_CR23","doi-asserted-by":"publisher","first-page":"109165","DOI":"10.1016\/j.celrep.2021.109165","volume":"35","author":"S Olalekan","year":"2021","unstructured":"Olalekan S, Xie B, Back R, Eckart H, Basu A. Characterizing the tumor microenvironment of metastatic ovarian cancer by single-cell transcriptomics. Cell Rep. 2021;35:109165.","journal-title":"Cell Rep"},{"key":"2146_CR24","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1158\/1078-0432.CCR-20-4394","volume":"27","author":"CM Laumont","year":"2021","unstructured":"Laumont CM, Wouters MCA, Smazynski J, Gierc NS, Chavez EA, Chong LC, Thornton S, Milne K, Webb JR, Steidl C, Nelson BH. Single-cell profiles and prognostic impact of Tumor-Infiltrating lymphocytes coexpressing CD39, CD103, and PD-1 in ovarian cancer. Clin Cancer Res. 2021;27:4089\u2013100.","journal-title":"Clin Cancer Res"},{"key":"2146_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13073-021-00922-x","volume":"13","author":"S Olbrecht","year":"2021","unstructured":"Olbrecht S, Busschaert P, Qian J, Vanderstichele A, Loverix L, Van Gorp T, Van Nieuwenhuysen E, Han S, Van den Broeck A, Coosemans A, et al. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification. Genome Med. 2021;13:111.","journal-title":"Genome Med"},{"key":"2146_CR26","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41467-022-28389-3","volume":"13","author":"IM Launonen","year":"2022","unstructured":"Launonen IM, Lyytik\u00e4inen N, Casado J, Anttila EA, Szab\u00f3 A, Haltia UM, Jacobson CA, Lin JR, Maliga Z, Howitt BE, et al. Single-cell tumor-immune microenvironment of BRCA1\/2 mutated high-grade serous ovarian cancer. Nat Commun. 2022;13:835.","journal-title":"Nat Commun"},{"key":"2146_CR27","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/s41467-021-21853-6","volume":"12","author":"R Fu","year":"2021","unstructured":"Fu R, Zhang P, Jin G, Wang L, Qi S, Cao Y, Martin C, Zhang Y. Versatility in acyltransferase activity completes Chicoric acid biosynthesis in purple Coneflower. Nat Commun. 2021;12:1563.","journal-title":"Nat Commun"},{"key":"2146_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fchem.2013.00040","volume":"1","author":"J Lee","year":"2013","unstructured":"Lee J, Scagel CF. Chicoric acid: chemistry, distribution, and production. Front Chem. 2013;1:40.","journal-title":"Front Chem"},{"key":"2146_CR29","doi-asserted-by":"crossref","unstructured":"Fu R, Zhang P, Deng Z, Jin G, Zhang Y. Chicoric acid provides better ultraviolet protection than the sum of its substrates in purple Coneflower plants. Ind Crops Prod 2021:170.","DOI":"10.1016\/j.indcrop.2021.113778"},{"key":"2146_CR30","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1200\/JCO.2004.03.121","volume":"22","author":"GK Dy","year":"2004","unstructured":"Dy GK, Bekele L, Hanson LJ, Furth A, Mandrekar S, Sloan JA, Adjei AA. Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. J Clin Oncol. 2004;22:4810\u20135.","journal-title":"J Clin Oncol"},{"key":"2146_CR31","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/sj.bjc.6601560","volume":"90","author":"U Werneke","year":"2004","unstructured":"Werneke U, Earl J, Seydel C, Horn O, Crichton P, Fannon D. Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer. 2004;90:408\u201313.","journal-title":"Br J Cancer"},{"key":"2146_CR32","doi-asserted-by":"publisher","first-page":"109144","DOI":"10.1016\/j.biopha.2019.109144","volume":"118","author":"X Sun","year":"2019","unstructured":"Sun X, Zhang X, Zhai H, Zhang D, Ma S. Chicoric acid (CA) induces autophagy in gastric cancer through promoting Endoplasmic reticulum (ER) stress regulated by AMPK. Biomed Pharmacother. 2019;118:109144.","journal-title":"Biomed Pharmacother"},{"key":"2146_CR33","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.jep.2012.08.032","volume":"143","author":"YL Tsai","year":"2012","unstructured":"Tsai YL, Chiu CC, Yi-Fu Chen J, Chan KC, Lin SD. Cytotoxic effects of Echinacea purpurea flower extracts and cichoric acid on human colon cancer cells through induction of apoptosis. J Ethnopharmacol. 2012;143:914\u20139.","journal-title":"J Ethnopharmacol"},{"key":"2146_CR34","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.neuropharm.2011.01.001","volume":"60","author":"K Kour","year":"2011","unstructured":"Kour K, Bani S. Augmentation of immune response by Chicoric acid through the modulation of CD28\/CTLA-4 and Th1 pathway in chronically stressed mice. Neuropharmacology. 2011;60:852\u201360.","journal-title":"Neuropharmacology"},{"key":"2146_CR35","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1089\/jmf.2021.K.0064","volume":"24","author":"SJ Park","year":"2021","unstructured":"Park SJ, Lee M, Kim D, Oh DH, Prasad KS, Eun S, Lee J. Echinacea purpurea extract enhances natural killer cell activity in vivo by upregulating MHC II and Th1-type CD4(+) T cell responses. J Med Food. 2021;24:1039\u201349.","journal-title":"J Med Food"},{"key":"2146_CR36","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","volume":"174","author":"KK Dijkstra","year":"2018","unstructured":"Dijkstra KK, Cattaneo CM, Weeber F, Chalabi M, van de Haar J, Fanchi LF, Slagter M, van der Velden DL, Kaing S, Kelderman S, et al. Generation of tumor-Reactive T cells by Co-culture of peripheral blood lymphocytes and tumor organoids. Cell. 2018;174:1586.e15981512.","journal-title":"Cell"},{"key":"2146_CR37","doi-asserted-by":"publisher","first-page":"108105","DOI":"10.1016\/j.celrep.2020.108105","volume":"32","author":"C Donato","year":"2020","unstructured":"Donato C, Kunz L, Castro-Giner F, Paasinen-Sohns A, Strittmatter K, Szczerba BM, Scherrer R, Di Maggio N, Heusermann W, Biehlmaier O, et al. Hypoxia triggers the intravasation of clustered Circulating tumor cells. Cell Rep. 2020;32:108105.","journal-title":"Cell Rep"},{"key":"2146_CR38","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nrc3726","volume":"14","author":"DM Gilkes","year":"2014","unstructured":"Gilkes DM, Semenza GL, Wirtz D. Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat Rev Cancer. 2014;14:430\u20139.","journal-title":"Nat Rev Cancer"},{"key":"2146_CR39","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1038\/s41388-021-01713-9","volume":"40","author":"J Liu","year":"2021","unstructured":"Liu J, Huang Z, Chen HN, Qin S, Chen Y, Jiang J, Zhang Z, Luo M, Ye Q, Xie N, et al. ZNF37A promotes tumor metastasis through transcriptional control of THSD4\/TGF-\u03b2 axis in colorectal cancer. Oncogene. 2021;40:3394\u2013407.","journal-title":"Oncogene"},{"key":"2146_CR40","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13046-017-0570-9","volume":"36","author":"S Riffle","year":"2017","unstructured":"Riffle S, Hegde RS. Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids. J Exp Clin Cancer Res. 2017;36:102.","journal-title":"J Exp Clin Cancer Res"},{"key":"2146_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","volume":"18","author":"X Jing","year":"2019","unstructured":"Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, Shu Y. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18:157.","journal-title":"Mol Cancer"},{"key":"2146_CR42","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:W556\u201360.","journal-title":"Nucleic Acids Res"},{"key":"2146_CR43","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48:W509\u201314.","journal-title":"Nucleic Acids Res"},{"key":"2146_CR44","first-page":"100625","volume":"5","author":"B Gy\u0151rffy","year":"2024","unstructured":"Gy\u0151rffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innov (Camb). 2024;5:100625.","journal-title":"Innov (Camb)"},{"key":"2146_CR45","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.ccell.2021.06.017","volume":"39","author":"C Hutton","year":"2021","unstructured":"Hutton C, Heider F, Blanco-Gomez A, Banyard A, Kononov A, Zhang X, Karim S, Paulus-Hock V, Watt D, Steele N, et al. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity. Cancer Cell. 2021;39:1227\u2013e12441220.","journal-title":"Cancer Cell"},{"key":"2146_CR46","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1158\/2159-8290.CD-19-1384","volume":"10","author":"Y Kieffer","year":"2020","unstructured":"Kieffer Y, Hocine HR, Gentric G, Pelon F, Bernard C, Bourachot B, Lameiras S, Albergante L, Bonneau C, Guyard A, et al. Single-Cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer. Cancer Discov. 2020;10:1330\u201351.","journal-title":"Cancer Discov"},{"key":"2146_CR47","doi-asserted-by":"publisher","first-page":"e1515","DOI":"10.1002\/ctm2.1515","volume":"13","author":"C Chen","year":"2023","unstructured":"Chen C, Guo Q, Liu Y, Hou Q, Liao M, Guo Y, Zang Y, Wang F, Liu H, Luan X, et al. Single-cell and Spatial transcriptomics reveal POSTN(+) cancer-associated fibroblasts correlated with immune suppression and tumour progression in non-small cell lung cancer. Clin Transl Med. 2023;13:e1515.","journal-title":"Clin Transl Med"},{"key":"2146_CR48","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12929-022-00888-x","volume":"29","author":"SC Lin","year":"2022","unstructured":"Lin SC, Liao YC, Chen PM, Yang YY, Wang YH, Tung SL, Chuang CM, Sung YW, Jang TH, Chuang SE, Wang LH. Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-\u03baB and TGF-\u03b22 signaling. J Biomed Sci. 2022;29:109.","journal-title":"J Biomed Sci"},{"key":"2146_CR49","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ccell.2021.04.004","volume":"39","author":"M Hornburg","year":"2021","unstructured":"Hornburg M, Desbois M, Lu S, Guan Y, Lo AA, Kaufman S, Elrod A, Lotstein A, DesRochers TM, Munoz-Rodriguez JL, et al. Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer. Cancer Cell. 2021;39:928\u2013e944926.","journal-title":"Cancer Cell"},{"key":"2146_CR50","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1097\/PAS.0000000000001503","volume":"44","author":"H Chen","year":"2020","unstructured":"Chen H, Molberg K, Strickland AL, Castrillon DH, Carrick K, Jiang Q, Niu S, Rivera-Colon G, Gwin K, Hinson S, et al. PD-L1 expression and CD8\u2009+\u2009Tumor-infiltrating lymphocytes in different types of Tubo-ovarian carcinoma and their prognostic value in High-grade serous carcinoma. Am J Surg Pathol. 2020;44:1050\u201360.","journal-title":"Am J Surg Pathol"},{"key":"2146_CR51","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41568-022-00503-z","volume":"22","author":"LE Kandalaft","year":"2022","unstructured":"Kandalaft LE, Dangaj Laniti D, Coukos G. Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation. Nat Rev Cancer. 2022;22:640\u201356.","journal-title":"Nat Rev Cancer"},{"key":"2146_CR52","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ygyno.2023.06.018","volume":"177","author":"S Pignata","year":"2023","unstructured":"Pignata S, Bookman M, Sehouli J, Miller A, Penson RT, Taskiran C, Anderson C, Hietanen S, Myers T, Madry R, et al. Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050\/GOG 3015\/ENGOT-OV39 trial of Atezolizumab for newly diagnosed stage III\/IV ovarian cancer. Gynecol Oncol. 2023;177:20\u201331.","journal-title":"Gynecol Oncol"},{"key":"2146_CR53","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1200\/JCO.21.00306","volume":"39","author":"KN Moore","year":"2021","unstructured":"Moore KN, Bookman M, Sehouli J, Miller A, Anderson C, Scambia G, Myers T, Taskiran C, Robison K, M\u00e4enp\u00e4\u00e4 J, et al. Atezolizumab, bevacizumab, and chemotherapy for newly diagnosed stage III or IV ovarian cancer: Placebo-Controlled randomized phase III trial (IMagyn050\/GOG 3015\/ENGOT-OV39). J Clin Oncol. 2021;39:1842\u201355.","journal-title":"J Clin Oncol"},{"key":"2146_CR54","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/cbdv.200690071","volume":"3","author":"ED Huntimer","year":"2006","unstructured":"Huntimer ED, Halaweish FT, Chase CC. Proliferative activity of Echinacea angustifolia root extracts on cancer cells: interference with doxorubicin cytotoxicity. Chem Biodivers. 2006;3:695\u2013703.","journal-title":"Chem Biodivers"},{"key":"2146_CR55","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00428-020-02751-6","volume":"477","author":"L de la Martin","year":"2020","unstructured":"de la Martin L, Westbom-Fremer S, Arildsen NS, Hartman L, Malander S, Kannisto P, M\u00e5sb\u00e4ck A, Hedenfalk I. PD-1\/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma. Virchows Arch. 2020;477:83\u201391.","journal-title":"Virchows Arch"},{"key":"2146_CR56","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1158\/1078-0432.CCR-15-1617","volume":"22","author":"MC Wouters","year":"2016","unstructured":"Wouters MC, Komdeur FL, Workel HH, Klip HG, Plat A, Kooi NM, Wisman GB, Mourits MJ, Arts HJ, Oonk MH, et al. Treatment regimen, surgical outcome, and T-cell differentiation influence prognostic benefit of Tumor-Infiltrating lymphocytes in High-Grade serous ovarian cancer. Clin Cancer Res. 2016;22:714\u201324.","journal-title":"Clin Cancer Res"},{"key":"2146_CR57","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","volume":"20","author":"BC Miller","year":"2019","unstructured":"Miller BC, Sen DR, Al Abosy R, Bi K, Virkud YV, LaFleur MW, Yates KB, Lako A, Felt K, Naik GS, et al. Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint Blockade. Nat Immunol. 2019;20:326\u201336.","journal-title":"Nat Immunol"},{"key":"2146_CR58","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.immuni.2019.12.010","volume":"52","author":"JG Egen","year":"2020","unstructured":"Egen JG, Ouyang W, Wu LC. Human Anti-tumor immunity: insights from immunotherapy clinical trials. Immunity. 2020;52:36\u201354.","journal-title":"Immunity"},{"key":"2146_CR59","doi-asserted-by":"crossref","unstructured":"Bhatt D, Kang B, Sawant D, Zheng L, Perez K, Huang Z, Sekirov L, Wolak D, Huang JY, Liu X et al. STARTRAC analyses of ScRNAseq data from tumor models reveal T cell dynamics and therapeutic targets. J Exp Med 2021, 218.","DOI":"10.1084\/jem.20201329"},{"key":"2146_CR60","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41586-020-2056-8","volume":"579","author":"TD Wu","year":"2020","unstructured":"Wu TD, Madireddi S, de Almeida PE, Banchereau R, Chen YJ, Chitre AS, Chiang EY, Iftikhar H, O\u2019Gorman WE, Au-Yeung A, et al. Peripheral T cell expansion predicts tumour infiltration and clinical response. Nature. 2020;579:274\u20138.","journal-title":"Nature"},{"key":"2146_CR61","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","volume":"25","author":"KE Yost","year":"2019","unstructured":"Yost KE, Satpathy AT, Wells DK, Qi Y, Wang C, Kageyama R, McNamara KL, Granja JM, Sarin KY, Brown RA, et al. Clonal replacement of tumor-specific T cells following PD-1 Blockade. Nat Med. 2019;25:1251\u20139.","journal-title":"Nat Med"},{"key":"2146_CR62","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1530\/ERC-18-0300","volume":"26","author":"HW Lin","year":"2019","unstructured":"Lin HW, Chiang YC, Sun NY, Chen YL, Chang CF, Tai YJ, Chen CA, Cheng WF. CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells. Endocr Relat Cancer. 2019;26:73\u201388.","journal-title":"Endocr Relat Cancer"},{"key":"2146_CR63","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1016\/j.immuni.2023.11.002","volume":"56","author":"T Taifour","year":"2023","unstructured":"Taifour T, Attalla SS, Zuo D, Gu Y, Sanguin-Gendreau V, Proud H, Solymoss E, Bui T, Kuasne H, Papavasiliou V, et al. The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer. Immunity. 2023;56:2755\u2013e27722758.","journal-title":"Immunity"},{"key":"2146_CR64","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1186\/s12967-023-04532-6","volume":"21","author":"S Ji","year":"2023","unstructured":"Ji S, Yu H, Zhou D, Fan X, Duan Y, Tan Y, Lang M, Shao G. Cancer stem cell-derived CHI3L1 activates the MAF\/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer. J Transl Med. 2023;21:721.","journal-title":"J Transl Med"},{"key":"2146_CR65","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1016\/j.immuni.2023.11.015","volume":"56","author":"M He","year":"2023","unstructured":"He M, Kok M. Chi3l1: new kid on the T cell Blockade. Immunity. 2023;56:2672\u20134.","journal-title":"Immunity"},{"key":"2146_CR66","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1186\/s12916-022-02696-4","volume":"20","author":"X Zhu","year":"2022","unstructured":"Zhu X, Sun L, Song N, He W, Xie B, Hu J, Zhang J, Yang J, Dai J, Bian D, et al. Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II-III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trial. BMC Med. 2022;20:493.","journal-title":"BMC Med"},{"key":"2146_CR67","doi-asserted-by":"crossref","unstructured":"Ma B, Akosman B, Kamle S, Lee CM, He CH, Koo JS, Lee CG, Elias JA. CHI3L1 regulates PD-L1 and anti-CHI3L1-PD-1 antibody elicits synergistic antitumor responses. J Clin Invest 2021, 131.","DOI":"10.1172\/JCI137750"},{"key":"2146_CR68","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41416-019-0718-9","volume":"122","author":"HJ Whitwell","year":"2020","unstructured":"Whitwell HJ, Worthington J, Blyuss O, Gentry-Maharaj A, Ryan A, Gunu R, Kalsi J, Menon U, Jacobs I, Zaikin A, Timms JF. Improved early detection of ovarian cancer using longitudinal multimarker models. Br J Cancer. 2020;122:847\u201356.","journal-title":"Br J Cancer"},{"key":"2146_CR69","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1002\/cncr.25196","volume":"116","author":"I Th\u00f6m","year":"2010","unstructured":"Th\u00f6m I, Andritzky B, Schuch G, Burkholder I, Edler L, Johansen JS, Bokemeyer C, Schumacher U, Laack E. Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer. Cancer. 2010;116:4114\u201321.","journal-title":"Cancer"},{"key":"2146_CR70","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.ajpath.2011.05.038","volume":"179","author":"CC Chen","year":"2011","unstructured":"Chen CC, Pekow J, Llado V, Kanneganti M, Lau CW, Mizoguchi A, Mino-Kenudson M, Bissonnette M, Mizoguchi E. Chitinase 3-like-1 expression in colonic epithelial cells as a potentially novel marker for colitis-associated neoplasia. Am J Pathol. 2011;179:1494\u2013503.","journal-title":"Am J Pathol"},{"key":"2146_CR71","doi-asserted-by":"publisher","first-page":"e18186","DOI":"10.1111\/jcmm.18186","volume":"28","author":"B Guan","year":"2024","unstructured":"Guan B, Li M, Cui D, Shen C, Hao Z, Li X. Single-cell transcriptomic analysis in clear cell renal cell carcinoma: Deciphering the role of APP within the tumour microenvironment. J Cell Mol Med. 2024;28:e18186.","journal-title":"J Cell Mol Med"},{"key":"2146_CR72","doi-asserted-by":"publisher","first-page":"e13591","DOI":"10.1111\/cpr.13591","volume":"57","author":"R Ma","year":"2024","unstructured":"Ma R, Zhou X, Zhai X, Wang C, Hu R, Chen Y, Shi L, Fang X, Liao Y, Ma L, et al. Single-cell RNA sequencing reveals immune cell dysfunction in the peripheral blood of patients with highly aggressive gastric cancer. Cell Prolif. 2024;57:e13591.","journal-title":"Cell Prolif"},{"key":"2146_CR73","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/iub.2804","volume":"76","author":"L Jiang","year":"2024","unstructured":"Jiang L, Zhao X, Li Y, Hu Y, Sun Y, Liu S, Zhang Z, Li Y, Feng X, Yuan J, et al. The tumor immune microenvironment remodeling and response to HER2-targeted therapy in HER2-positive advanced gastric cancer. IUBMB Life. 2024;76:420\u201336.","journal-title":"IUBMB Life"},{"key":"2146_CR74","doi-asserted-by":"publisher","first-page":"900853","DOI":"10.3389\/fpubh.2022.900853","volume":"10","author":"M Li","year":"2022","unstructured":"Li M, Duan X, Xiao Y, Yuan M, Zhao Z, Cui X, Wu D, Shi J. BUB1 is identified as a potential therapeutic target for pancreatic cancer treatment. Front Public Health. 2022;10:900853.","journal-title":"Front Public Health"},{"key":"2146_CR75","doi-asserted-by":"publisher","first-page":"914120","DOI":"10.3389\/fcell.2022.914120","volume":"10","author":"H Song","year":"2022","unstructured":"Song H, Lou C, Ma J, Gong Q, Tian Z, You Y, Ren G, Guo W, Wang Y, He K, Xiao M. Single-Cell transcriptome analysis reveals changes of tumor immune microenvironment in oral squamous cell carcinoma after chemotherapy. Front Cell Dev Biol. 2022;10:914120.","journal-title":"Front Cell Dev Biol"},{"key":"2146_CR76","doi-asserted-by":"publisher","first-page":"110852","DOI":"10.1016\/j.intimp.2023.110852","volume":"124","author":"Y Wan","year":"2023","unstructured":"Wan Y, Jiang J, Chen M, Han X, Zhong L, Xiao F, Liu J, Liu J, Li H, Huang H, Hou J. Unravelling the imbalanced Th17-like cell differentiation by single-cell RNA sequencing in multiple myeloma. Int Immunopharmacol. 2023;124:110852.","journal-title":"Int Immunopharmacol"},{"key":"2146_CR77","doi-asserted-by":"crossref","unstructured":"Wu C, Wang X, Shang H, Wei H. Construction of a Humanized PBMC-PDX Model to Study the Efficacy of a Bacterial Marker in Lung Cancer Immunotherapy. Dis Markers 2022;2022:1479246.","DOI":"10.1155\/2022\/1479246"},{"key":"2146_CR78","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/15384047.2019.1670520","volume":"21","author":"X Lin","year":"2020","unstructured":"Lin X, Zeng T, Lin J, Zhang Q, Cheng H, Fang S, Lin S, Chen Y, Xu Y, Lin J. Establishment of humanized tumor microenvironment mouse models based on the injection of peripheral blood mononuclear cells and IFN-\u03b3 to evaluate the efficacy of PD-L1\/PD-1-targeted immunotherapy. Cancer Biol Ther. 2020;21:130\u20138.","journal-title":"Cancer Biol Ther"},{"key":"2146_CR79","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1080\/19420862.2018.1518948","volume":"10","author":"S Lin","year":"2018","unstructured":"Lin S, Huang G, Cheng L, Li Z, Xiao Y, Deng Q, Jiang Y, Li B, Lin S, Wang S, et al. Establishment of peripheral blood mononuclear cell-derived humanized lung cancer mouse models for studying efficacy of PD-L1\/PD-1 targeted immunotherapy. MAbs. 2018;10:1301\u201311.","journal-title":"MAbs"},{"key":"2146_CR80","unstructured":"R Core Team R. R: A language and environment for statistical computing. 2013."},{"key":"2146_CR81","doi-asserted-by":"crossref","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, Zager M, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573\u2013e35873529.","DOI":"10.1016\/j.cell.2021.04.048"},{"key":"2146_CR82","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, Chak S, Naikawadi RP, Wolters PJ, Abate AR, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20:163\u201372.","journal-title":"Nat Immunol"},{"key":"2146_CR83","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, et al. ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2:100141.","journal-title":"Innov (Camb)"},{"key":"2146_CR84","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"2146_CR85","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417\u201325.","journal-title":"Cell Syst"},{"key":"2146_CR86","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S, Gonz\u00e1lez-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G, Rambow F, Marine JC, Geurts P, Aerts J, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017;14:1083\u20136.","journal-title":"Nat Methods"},{"key":"2146_CR87","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, Myung P, Plikus MV, Nie Q. Inference and analysis of cell-cell communication using cellchat. Nat Commun. 2021;12:1088.","journal-title":"Nat Commun"},{"key":"2146_CR88","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray NL, Pimentel H, Melsted P, Pachter L. Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol. 2016;34:525\u20137.","journal-title":"Nat Biotechnol"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02146-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02146-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02146-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T13:55:15Z","timestamp":1741960515000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02146-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2146"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02146-7","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"16 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and received full approval from the Medical Ethics Review Committee of the Affiliated Hospital of Qingdao University (QYFYWZLL27943).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All the authors have reviewed and approved the final version of the manuscript being submitted.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author agreement"}}],"article-number":"137"}}